Rheumatoid Arthritis
Meral K. El Ramahi, MD MeralElRamahiMD
3 years 11 months ago
#ACR21 Abst#0182
Does tenderness in non-swollen joints of PsA or RA pts portend inflammation & radiographic damage?
⭐️NO, except in early PsA!
➡️Abnormal PDUS associated w/ radiographic progression vs tenderness otherwise
#ACRBest @Rheumnow @uptoTate
https://t.co/iB1E0SL45e https://t.co/3Q30LeCMH4
Meral K. El Ramahi, MD MeralElRamahiMD
3 years 11 months ago
#ACR21 Abst#0271
➡️Patients 40-75 yo w/ RA dx in the prior 5 yrs have ⬆️ prevalence of subclinical athero vs age-matched controls.
→ Should we consider obtaining a carotid US at time of RA dx & monitor per risk status to help optimize CV risk? @Rheumnow
https://t.co/3PpHIRk984 https://t.co/ChRTU7zACk
Aurelie Najm AurelieRheumo
3 years 11 months ago
Blurred line indeed, one could argue that a patient with ACPA+, arthralgia and sub-clinical inflammation detected on MRI is already transitioning toward early RA and fall into the category of patients we should treat anyway. https://t.co/Y1JceOijK0
Akhil Sood MD AkhilSoodMD
3 years 11 months ago
Exciting day at #ACR21
I wrote an article discussing COVID 19 in #RheumatoidArthritis discussing the following abstracts
0097 by Hasseli
1445 by @NamrataRheum
L04 by @rheum_cat & @rheum_covid
@rheumnow #COVID19 #RA #JAK #Rituximab
https://t.co/g32ZYHBjQY
Janet Pope Janetbirdope
3 years 11 months ago
Blurred line btwn RA, preRA & RA prevention which makes interpretation of RCTs problematic. I’ve learned that if pt has RA not meeting criteria, some Rx ⬇️chance of RA over time-MTX, now #Abatacept but was it RA anyway AND what happens when you stop Rx? #ACR21 @RheumNow abst#0505 https://t.co/HwivsITvCQ
Md Yuzaiful Md Yusof Yuz6Yusof
3 years 11 months ago
#ACR21 #Abstr0437 OK, so RTX affects #COVID vaccine but some pts need RTX. Factors predicting response to vaccine:
RA vs AAV/IIM
Higher IgG
Longer time-to-RTX
Lower RTX courses Number.
Prediction Calculator is developed but need ext. validation #RheumNow https://t.co/iXSaGQ76hS https://t.co/WQAV3GRPBz
The opening of ACR2 Convergence was a hit for all who signed up and viewed in. The day included the presidential address by outgoing president Dr. David Karp (UT Southwestern) and a keynote talk and interview with Dr. Seema Yasmin (Stanford).
The Year in Review featured a clinical vs basic science Brigham and Women’s Hospital faceoff between its two faculty, Dr. Karen Costenbader and Dr. Michael Brenner.
Appropriate assessment and management of comorbidities and multimorbidity in patients with RA is vital for overall health and well-being of the patient, as well as to encourage treatment adherence, and address social, psychological and quality of life factors.
Akhil Sood MD AkhilSoodMD
3 years 11 months ago
Abst # 0494
Dowell & colleagues showed that in RA patients using RISE registry
- disease activity correlated with burden of comorbidities
- this was linked to areas of low SES (ADI > 80) who received primarily Medicaid Coverage
https://t.co/xkdVnieHB2 #ACR21 @RheumNow https://t.co/jyZbV64qVz
Dr. Rachel Tate uptoTate
3 years 11 months ago
Insurance type, not race or distance to care, assoc'd w/ RA dz activity & burden. We need ^ rheums to care for socially deprived, rural, high comorbidity, Medicaid-covered RA pts w/ enhanced reimbursement & access to tx. Abs 0494 #ACR21 #RheumNow @RheumNow https://t.co/0es0i24gkS https://t.co/pBvhFR2DqE
Poster Hall